(HMC) Honda Motor - Overview
Stock: Vehicles, Engines, Aircraft, Finance
| Risk 5d forecast | |
|---|---|
| Volatility | 31.8% |
| Relative Tail Risk | -3.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -20.76 |
| Character TTM | |
|---|---|
| Beta | 0.445 |
| Beta Downside | 0.449 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.20% |
| CAGR/Max DD | 0.12 |
EPS (Earnings per Share)
Revenue
Description: HMC Honda Motor March 05, 2026
Honda Motor Co., Ltd. (HMC) is a diversified manufacturer of motorcycles, automobiles, and power products. The company operates globally across four segments: Motorcycle Business, Automobile Business, Financial Services Business, and Power Product and Other Businesses.
The Automobile Business segment manufactures passenger cars, light trucks, and mini vehicles. This sector is characterized by significant capital expenditure requirements for research and development and manufacturing facilities. The Motorcycle Business segment produces various motorcycle types and off-road vehicles. The Financial Services Business provides retail lending, leasing, and wholesale financing, common for large automotive manufacturers to support vehicle sales. The Power Product and Other Businesses segment includes general-purpose engines, lawn mowers, generators, and also HondaJet aircraft.
Honda distributes products and provides after-sales services through a network of retail dealers, independent distributors, and licensees. Further research on platforms like ValueRay can provide detailed financial metrics and historical performance data.
Headlines to watch out for
- Automobile sales volume and pricing dictate revenue growth
- Motorcycle demand in emerging markets impacts profitability
- Financial services segment interest rates affect net income
- Raw material costs and supply chain stability influence margins
- Yen exchange rate fluctuations impact international earnings
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 498.78b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.12 > 1.0 |
| NWC/Revenue: 15.32% < 20% (prev 15.58%; Δ -0.26% < -1%) |
| CFO/TA 0.02 > 3% & CFO 816.57b > Net Income 498.78b |
| Net Debt (8700.29b) to EBITDA (1675.64b): 5.19 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.30b) vs 12m ago -16.06% < -2% |
| Gross Margin: 20.48% > 18% (prev 0.21%; Δ 2.03k% > 0.5%) |
| Asset Turnover: 66.74% > 50% (prev 69.35%; Δ -2.61% > 0%) |
| Interest Coverage Ratio: 13.63 > 6 (EBITDA TTM 1675.64b / Interest Expense TTM 60.28b) |
Altman Z'' 2.69
| A: 0.10 (Total Current Assets 12376.88b - Total Current Liabilities 9094.05b) / Total Assets 32849.55b |
| B: 0.34 (Retained Earnings 11293.38b / Total Assets 32849.55b) |
| C: 0.03 (EBIT TTM 821.84b / Avg Total Assets 32111.85b) |
| D: 0.71 (Book Value of Equity 14203.38b / Total Liabilities 20071.09b) |
| Altman-Z'' Score: 2.69 = A |
Beneish M -2.58
| DSRI: 1.07 (Receivables 4085.28b/3872.20b, Revenue 21432.16b/21758.03b) |
| GMI: 1.05 (GM 20.48% / 21.49%) |
| AQI: 1.61 (AQ_t 0.52 / AQ_t-1 0.33) |
| SGI: 0.99 (Revenue 21432.16b / 21758.03b) |
| TATA: -0.01 (NI 498.78b - CFO 816.57b) / TA 32849.55b) |
| Beneish M-Score: -2.58 (Cap -4..+1) = A |
What is the price of HMC shares?
Over the past week, the price has changed by -8.64%, over one month by -18.15%, over three months by -16.05% and over the past year by -11.03%.
Is HMC a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.6 | 28.1% |
| Analysts Target Price | 32.6 | 28.1% |
HMC Fundamental Data Overview March 15, 2026
P/E Trailing = 10.9702
P/E Forward = 8.0257
P/S = 0.0016
P/B = 0.4269
P/EG = 3.4538
Revenue TTM = 21432.16b JPY
EBIT TTM = 821.84b JPY
EBITDA TTM = 1675.64b JPY
Long Term Debt = 8292.27b JPY (from longTermDebt, last quarter)
Short Term Debt = 4943.48b JPY (from shortTermDebt, last quarter)
Debt = 13546.81b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 8700.29b JPY (from netDebt column, last quarter)
Enterprise Value = 14082.86b JPY (5382.57b + Debt 13546.81b - CCE 4846.52b)
Interest Coverage Ratio = 13.63 (Ebit TTM 821.84b / Interest Expense TTM 60.28b)
EV/FCF = 1000.0x (Enterprise Value 14082.86b / FCF TTM 11.83b)
FCF Yield = 0.08% (FCF TTM 11.83b / Enterprise Value 14082.86b)
FCF Margin = 0.06% (FCF TTM 11.83b / Revenue TTM 21432.16b)
Net Margin = 2.33% (Net Income TTM 498.78b / Revenue TTM 21432.16b)
Gross Margin = 20.48% ((Revenue TTM 21432.16b - Cost of Revenue TTM 17043.54b) / Revenue TTM)
Gross Margin QoQ = 20.25% (prev 20.37%)
Tobins Q-Ratio = 0.43 (Enterprise Value 14082.86b / Total Assets 32849.55b)
Interest Expense / Debt = 0.10% (Interest Expense 14.06b / Debt 13546.81b)
Taxrate = 30.21% (75.15b / 248.78b)
NOPAT = 573.59b (EBIT 821.84b * (1 - 30.21%))
Current Ratio = 1.36 (Total Current Assets 12376.88b / Total Current Liabilities 9094.05b)
Debt / Equity = 1.09 (Debt 13546.81b / totalStockholderEquity, last quarter 12465.66b)
Debt / EBITDA = 5.19 (Net Debt 8700.29b / EBITDA 1675.64b)
Debt / FCF = 735.3 (Net Debt 8700.29b / FCF TTM 11.83b)
Total Stockholder Equity = 12269.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.55% (Net Income 498.78b / Total Assets 32849.55b)
RoE = 4.07% (Net Income TTM 498.78b / Total Stockholder Equity 12269.12b)
RoCE = 4.00% (EBIT 821.84b / Capital Employed (Equity 12269.12b + L.T.Debt 8292.27b))
RoIC = 4.33% (NOPAT 573.59b / Invested Capital 13242.26b)
WACC = 2.20% (E(5382.57b)/V(18929.38b) * Re(7.55%) + D(13546.81b)/V(18929.38b) * Rd(0.10%) * (1-Tc(0.30)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.19%
[DCF] Terminal Value 80.82% ; FCFF base≈11.83b ; Y1≈7.77b ; Y5≈3.54b
[DCF] Fair Price = N/A (negative equity: EV 112.92b - Net Debt 8700.29b = -8587.37b; debt exceeds intrinsic value)
EPS Correlation: 20.94 | EPS CAGR: 9.16% | SUE: 0.02 | # QB: 0
Revenue Correlation: 88.02 | Revenue CAGR: 9.46% | SUE: 0.04 | # QB: 0
EPS next Year (2027-03-31): EPS=3.48 | Chg7d=-0.313 | Chg30d=-0.560 | Revisions Net=-1 | Growth EPS=+49.3% | Growth Revenue=+4.5%